Non-Operative Management Approaches for Urinary Incontinence
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests new methods to manage urinary incontinence in women without surgery. It evaluates the effectiveness of different combinations of patient education, nurse support, and a ChatBot (an interactive digital assistant) in improving symptoms. Participants will be divided into three groups to test these approaches. Women visiting a primary care provider at University Hospitals Cleveland who experience any level of urinary incontinence may be suitable for this trial. As an unphased trial, it offers participants the chance to explore innovative, non-surgical solutions for urinary incontinence.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that nurse guidance is generally well-received for managing urinary incontinence in women. Studies have found that nurse-led programs help women care for themselves and manage symptoms effectively. No major side effects have been reported, making this a safe option for many.
Regarding chatbots, studies provide real-world evidence supporting their safety and effectiveness. Chatbots help patients understand and manage their condition better. They are easy to use and safe, with no significant risks reported.
Patient education is a common and safe approach, focusing on teaching patients about their condition and how to manage it. This method has been widely used without any serious safety concerns.
Overall, current research considers these treatments—nurse guidance, chatbots, and patient education—safe and well-tolerated.12345Why are researchers excited about this trial?
Researchers are excited about these non-operative management approaches for urinary incontinence because they offer innovative ways to support patients without surgery or medication. The combination of patient education with nurse navigation stands out by providing personalized guidance and support, helping patients better manage their condition. Adding a ChatBot to the mix introduces a modern, accessible way for patients to get real-time information and support, making it easier to stay informed and engaged in their care. These approaches aim to empower patients with tools and knowledge, potentially improving their quality of life with minimal intervention.
What evidence suggests that this trial's treatments could be effective for urinary incontinence?
This trial will explore various non-operative management approaches for urinary incontinence. Participants in Arm 1 will receive Patient Education, which research has shown can significantly reduce instances of urinary incontinence. In one study, 61% of participants experienced at least a 50% reduction in incontinence episodes after receiving educational support.
Arm 2 will combine Patient Education with Nurse Navigation. Adding guidance from nurses appears to enhance outcomes, particularly for nursing home residents, by improving their ability to manage incontinence.
Arm 3 will include Patient Education, Nurse Navigation, and a ChatBot. Early results suggest that chatbots effectively address common questions about urinary incontinence and provide helpful information. This approach aims to equip women with practical knowledge and support, potentially leading to better management of urinary incontinence.678910Who Is on the Research Team?
Adonis Hijaz, MD
Principal Investigator
University Hospitals Cleveland Medical Center
Goutham Rao, MD
Principal Investigator
University Hospitals Cleveland Medical Center
Are You a Good Fit for This Trial?
This trial is for women over 18 who are experiencing urinary incontinence and have visited the University Hospitals Cleveland Primary Care Institute. Participants should score at least 1 on a specific questionnaire about incontinence.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to one of three groups: Usual Care plus Patient Educational Opportunities, Nurse Navigation, or Nurse Navigation and ChatBot, with ongoing management and education
Follow-up
Participants are monitored for adherence to therapy and improvement in symptoms, with data collection from medical records and questionnaires
What Are the Treatments Tested in This Trial?
Interventions
- ChatBot
- Nurse Navigation
- Patient Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Hospitals Cleveland Medical Center
Lead Sponsor
Adonis Hijaz, MD
Lead Sponsor